OPAD approaches its May 4 Q1 results carrying a meaningful short interest position — and one that has been growing fast heading into the release.
Short interest has climbed to 11.7% of the free float, up 14% in just one week. That is a sharp reversal from the prior month, when SI had been falling. The ORTEX short score now reads 70.8 — placing OPAD in roughly the bottom 3rd percentile of the full universe on this metric, meaning shorts are more concentrated here than in almost all peers. Days to cover runs at nearly six days, meaning it would take the equivalent of six full trading sessions of average volume to unwind the current short book. The borrow market has eased somewhat — cost to borrow has dipped to 5.3%, down from above 6.5% in early April — but availability remains tight relative to the size of the position. Availability is well below the levels seen earlier in the year, reflecting continued demand from short sellers even as the stock has rallied 37% over the past month to close at $0.79.
That 37% monthly gain is the central tension going into Monday's print. The stock has recovered sharply from its lows, yet the short community has been adding rather than retreating. Options positioning reflects neither panic nor conviction: the put/call ratio is a modest 0.07, barely above its 20-day average and well short of the 52-week peak of 0.51. Call volume remains dominant, suggesting some participants are positioned for continued upside — but the option market's overall activity is limited on a name this small, and the reading carries less weight than on a liquid large-cap.
The fundamental debate is starkly drawn. Bulls point to Offerpad's pivot toward asset-light services, which management has flagged as the path to improving margins and reducing its reliance on capital-intensive cash offers. A capital raise last year also shored up liquidity. Bears push back hard: EBITDA estimates for 2025 and 2026 have come down, cash offer volume has declined, and the company's adjusted EBITDA loss of -$4.8 million in the most recent quarter came in well below consensus. Analyst coverage is thin and cautious — Keefe, Bruyette & Woods cut its target to $1.00 in February after the last earnings release, while maintaining a Market Perform rating. The most recent analyst price target consensus of $1.75 sits above the current price, but the gap between that target and where the stock actually trades has narrowed dramatically since the recent run-up, and the consensus data is now several months old.
Two institutional footnotes are worth noting. Davidson Kempner entered a new position of over 2 million shares in early January, and Citadel built a fresh position of similar size around the same time — both disclosed in the most recent filings. First American Financial remains the largest holder at 10.8% of shares. Against that, insider activity has been dormant for nearly a year, with the most recent disclosed trades being small routine sells in mid-2025.
The May 4 print will test whether Offerpad's asset-light services growth has been enough to offset the cash offer volume weakness — and whether the 37% price recovery since March is supported by anything in the operating data.
See the live data behind this article on ORTEX.
Open OPAD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
